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Abstract
Concerning recent Italian laws and jurisprudential statements,
guidelines application involves several difficulties in clinical practice,
regarding prevention, diagnosis and therapy of venous thromboem-
bolism. International scientific community systematically developed
statements about this disease in order to optimize the available re-
sources in prophylaxis, diagnosis and therapy. Incongruous prevention,
missed or delayed diagnosis and/or inadequate treatment of this dis-
ease can frequently give rise to medico-legal litigation.
Riassunto
L’applicazione in ambito clinico delle linee guida e buone pratiche ac-
creditate, alla luce delle recenti pronunce legislative e giurisprudenziali,
presenta molteplici criticità, con particolare riferimento alla preven-
zione, diagnosi e cura del tromboembolismo venoso. A fronte della com-
plessità del fenomeno, della difficoltà di gestione, dei costi correlati alla
conseguente morbilità e mortalità di tale entità clinica la comunità
scientifica internazionale ha cercato di delineare delle regole di con-
dotta universalmente condivise al fine di ottimizzare le risorse disponi-
bili nella fase di prevenzione e gestione diagnostico-terapeutica. Al con-
tempo, sempre più frequentemente vengono paventate ipotesi di re-
sponsabilità professionale per incongrua profilassi, mancata o ritardata
diagnosi e/o insoddisfacente terapia del tromboembolismo venoso.
Introduction
Evolutions of technology and progress in scientific knowledge have
led an increasing waiting for “result” of the health practice. Sometimes
inadequate information about complications and highlighting of the
positive outcomes resulted in a lower acceptance of an unfavourable
consequence of each diagnostic and therapeutic performance. The cur-
rent socio-cultural attitude tends to give to the Medicine all-powerful-
ness in complete healing, tending to attribute any suspected failure to
“medical malpractice” [1].
It should be remembered that the physician is subject to a profes-
sional contract towards the patient: in the Italian jurisprudential doc-
trine this contract is defined as “social contact”. This definition allows
to standardize the rules of medical behaviour and to delineate specific
duties of protection to the patient (Civil Cassation, SS.UU., judgment
11.01.2008 n. 577). The so-called “contractualization” of medical lia-
bility outlines a professional relationship in which the patient is a cred-
itor of the medical practice while the physician is required to offer its
practice according to the parameters of diligence, prudence and
“peritia”: in this socio-cultural context, the common relationship be-
tween the patient and the physician has profoundly changed, consoli-
dating an increased reading of medical liability in face of a strength-
ening of the concept of patient’s health protection.
In order to defend themselves from possible litigation, physicians
apply or avoid specific judgment, inspired more for the purpose to re-
move or minimize the risk of medico-legal consequences that to ensure
the patient’s health (so-called “defensive medicine”). It is also possible
an uncritical agreement to the recommendations contained in the
“guidelines”, refraining from those clinical measures not provided by
guidelines but necessary for the patient’s health [2].
After the Italian Decree 158/2012 (so-called “Balduzzi’s Decree”),
only a proper application of statements reported in guidelines could be
considered a positive factor in the medico-legal assessment of clinical
practice. Conversely, an unjustified and erroneous application of guide-
lines may represent a wrongful conduct not sufficiently expert, prudent
and diligent, rather than a judgement of “excuse” of medical error.
No
n c
om
me
rci
al 
us
e o
nly
[page 8] [Monaldi Archives for Chest Disease Cardiac Series 2015; 84:25]
Original Article
definitive statement of the correct procedure. Guidelines constitute a
general guide to be followed, subject to the medical practitioner’s
judgement.
While it may be possible to develop explicit criteria for diagnosis and
treatment of certain pathologies, the current state of medical knowl-
edge is insufficient to support the development of explicit and correct
statement for all clinical situations. Furthermore, the intricate process
of clinical guidelines development, to which are not extraneous orga-
nizational and economic assessments, limit the role that guidelines
play in the litigation process [8].
The Italian Courts recently pointed out that the compliance with
guidelines should not be the only parameter for evaluating medical
practice. The properties of the single clinical case could justify diag-
nostic or therapeutic decisions that depart from guidelines. This ap-
proach is in line with the medico-legal Italian literature: “Medical
guidelines are characterized by the universal meaning of the statements
provided, applicable to all cases with similar characteristics to the the-
oretical model… There are critical profiles about the relevance of such
statements and their degree of prescriptively, in relation to the indi-
vidual nature – as addressed to the single clinical case – which is proper
of medical activities” [9].
Despite these notes and the risk more often reported as a misinter-
pretation of the guidelines meaning, Courts increasingly admitted
guidelines as evidence of the legal standard of care to proof of rebuttal
of medical malpractice with the help of expert witness testimony.
In such a complex operating system the physicians are bound on the
one hand to the respect of the diagnostic-therapeutic statements, al-
though not prescriptive, and on the other hand to the principles of med-
ical ethics which, as noted, support medical judgement autonomy in
the protection of patient health (art. 3 and 4 of the Italian Code of Med-
ical Ethics). Italian Code of Medical Ethics, recently revised, pointed
out that the physician must support their technical and professional ex-
perience through the effectiveness and appropriateness values, up-
dating scientific knowledge available, through a continuous moni-
toring and review of literature.
It must finally be emphasized that a misinterpretation of the rule in-
troduced by Decree 158/2012, resulting slavish observance of the guide-
lines, in the expectation of an exclusion of medical liability, seems to
further encourage conducts of “defensive medicine”, whose elimination
was one of the main goals of the Italian legislature at the time of en-
actment.
Medical liability in prevention, diagnosis 
and treatment of venous thromboembolism
The scientific literature has largely focused on the need of throm-
boembolic prophylaxis, providing efficacy evidence, when performed in
the manner and appropriate times [10,11].
The careful evaluation and identification of thromboembolic risk is
essential to set the appropriate preventive strategy and reducing the
mortality and morbidity associated with this disability. Assessing pa-
tients for risk is the basis of most of the clinical trials on prevention of
venous thromboembolism (VTE): the clinical data that have resulted in
hospitalization and treatment represent undoubtedly the major risk
factors, as well as also outlined in the guidelines of the American Col-
lege of Chest Physicians (ACCP), recently subjected to further review
and publication [12].
In order to estimate the individual risk of each patient, several VTE
risk assessment models based on both individual predisposing factors
and on acquired clinical conditions have been developed and clinically
evaluated [13-16].
With specific reference to thromboembolic disease, the International
scientific community has tried to outline statements universally shared
in order to standardize and improve patient management and to opti-
mize the available funds in prevention and diagnostic-therapeutic
management, despite the clinical heterogeneity, the difficulty of treat-
ment and the costs related to the consequent morbidity and mortality of
this disease.
Despite the periodically publication of many “evidenced-based”
statements in order to assist clinicians, several studies report a level of
guidelines adherence surprisingly low [3,4]. At the same time, more
frequently hypotheses of medical liability for incongruous prophylaxis,
failure or delay in diagnosis and/or unsatisfactory treatment of venous
thromboembolism are feared.
Guidelines and good medical practice: 
medico-legal aspects
The Italian Decree Law 158/12, converted into Law 189/12 (“Bal-
duzzi’s Decree”), establishes that “The operator of the health care pro-
fession that in carrying out its activities adheres to guidelines and good
practices, recognized by the scientific community, is not liable for slight
negligence…”.
In this law there is explicit reference to guidelines, as systematically
developed statements produced through a methodical process in order
to assist practitioners and patients decisions about appropriate health
care for specific clinical circumstances, according to the classic defini-
tion developed in 1992 [5]. The process of guideline development
should be multidisciplinary with a panel consisting of representatives
of all relevant groups should be convened: this procedure is increas-
ingly based on a thorough evaluation of the best available evidence, in-
cluding, when appropriate, meta-analysis of published research studies
on the outcomes of various treatment options, rather than the con-
sensus of expert panels. The statements are intended to be “a distilla-
tion of current evidence and opinion on best practice” [6,7].
Clinical practice guidelines are one component of good medical de-
cision-making, which takes into account patient’s preferences and
values, clinician’s values and experience and the available resources.
For these reasons, guidelines cannot take prescriptive value, but rather
suggestive of an appropriate practice, while maintaining to the physi-
cians any independent decision, when compared these statements with
the detailed properties of each case.
The jurisprudential Italian expressions were aligned to this doctrinal
interpretation; the Courts pointed out that: “…the doctor is always re-
quired to exercise their practices considering the particular circum-
stances of the real case and the condition of the patient, respecting pa-
tient’s preferences, overcoming statemen crystallized in medical proto-
cols…” (Cass. Pen. Sec. IV n. 19354, March 2007).
It is also emblematic as underlined in the following sentence: “The
simple execution of the statements contained in the guidelines does not
exclude the liability of negligent practitioner, because it is up to the
physician treating the patient with the diagnostic and therapeutic tools
approved by medical science, without being influenced by the needs of
different nature or provisions, considerations, evaluations, that are not
relevant to the tasks assigned by law… The physician is not required to
comply with those directives in conflict with patient’s care… degrading
their professionalism and mission-level accountancy…” (Cass. Pen.
Sec. IV n. 8254, November 23).
Despite it is certainly possible that guidelines could be produced as
evidence of what constitutes reasonable conduct by a medical practi-
tioner for the purposes of assessing whether the practitioner’s duty of
care had been breached in a medical negligence action, they are not a
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The incidence of venous thromboembolism increase dramatically in
tandem with the number of risk factors identified in patients (such as
age, family history, acute medical illness, thrombophilic diathesis, pro-
tracted immobilization, pregnancy, cancer, major or minor surgeries,
etc.).
The thromboembolic risk factor score, calculated for any patient, pro-
vides helpful starting information to determine the type and length of
pharmacological and/or mechanical prophylaxis to administer [17].
The potential for legal liability with antithrombotic therapy begins
when the patient is first considered or should have been considered for
antithrombotic prophylaxis.
For these reasons, in this decisive preventive step, it is recom-
mended to consider all VTE risk factors in order to adequately assess
not only the thrombo-embolic risk, but also the haemorrhagic risk.
Although there are many evidence-based guidelines which show in-
dications for VTE prevention, many studies have revealed high rate of
malpractice in using prophylaxis. In medico-legal evaluation attention
is often focused almost exclusively on the use or not to pharmacolog-
ical prophylaxis: the administration of anticoagulant therapy is often
considered sufficient reason to exclude a possible medical negligence.
In order to prove that a medical practitioner has fulfilled a duty of care
to the patient, it is necessary to evaluate any necessary combination
with mechanical prophylaxis, the anticoagulant class used, the dose,
the duration of treatment and monitoring of it, the chronology of the
prophylaxis beginning. Appropriate prophylaxis is achieved only by pro-
viding the patient with the appropriate drug (or device) at the appro-
priate dose and for the appropriate duration [18].
Despite there is unanimous and authoritative consensus on pre-
scribing or not prescribing thromboembolic preventive measures, some
issues are still debated and different advices are provided by the sev-
eral guidelines developed on this item, for example on the duration and
the correct time to start prophylaxis, as well as on the proper selection
and administration of anticoagulant drugs available. Critical issue is,
in particular, the administration of chemical prophylaxis, both for the
need to use the correct dose for the particular clinical case, both for the
importance of an adequate monitoring, and both for the compliance,
not always adequate, for the patient during the maintenance of care
outside the hospital. For these technical hitches, the use of standard-
ized practices is basic in order to avoid or at least reduce the risk of
malpractice.
In the diagnostic phase, the often aspecificity and heterogeneity
of the clinical cases makes it difficult for a timely and correct diag-
nosis of thrombo-embolic disease. In the absence of clinical pathog-
nomonic signs of a pulmonary embolism, the clinical diagnosis re-
quires a high index of suspicion and the start of the appropriate di-
agnostic instrumental methods in order to allow a more accurate di-
agnostic definition.
As demonstrated in several autopsy-based studies, approximately
two thirds of cases suffering from pulmonary embolism are not ade-
quately identified ante mortem. In the 50s, forensic studies had shown
that in only 11-12% of patients the diagnosis was correctly suspected
[19]. With the introduction of more appropriate diagnostic methods,
there has been an improvement of diagnostic accuracy: in a study con-
ducted between 1973 and 1977, Goldhaber et al. reported correct ante
mortem diagnosis in 30% of cases (confidence interval [CI] 95%, 18-
44%) [20]. In line with these data, another study carried out between
1980 and 1984 reported a percentage of correct diagnosis in 32% of
cases (95% CI, 19-48%) [21]. In 1990, Daisley showed that pulmonary
embolism was the major contributing factor to the cause of death in
10% of the 610 autopsies performed in a general hospital population; of
the patients dying from major pulmonary embolism, in only 19.7% the
diagnosis was suspected antemortem [22].
Despite the significant improvement in diagnosis and management
of pulmonary embolism, the difficulty of making a correct and timely di-
agnosis still persists; at the same time, this disease represent an im-
portant cause of morbidity and mortality among hospitalized patients
in absence of an adequate and timely treatment.
It must also be highlighted that the diagnostic evidence of pul-
monary embolism occurs in only 20-30% of suspected cases. For these
reasons, the literature on the subject shows a constant interest in an-
temortem accuracy diagnosis in order to allow an appropriate thera-
peutic approach resulting in reduction of mortality from one side and
on the other in optimizing funds by reducing unnecessary and often in-
vasive examinations.
For this purpose in recent years clinical assessment of pretest prob-
ability become a crucial tool in the diagnostic approach of patients with
suspected pulmonary embolism [23]. Despite clinical judgement and
technical findings have poor diagnostic value per se in terms of predic-
tive accuracy, the combination of several items is crucial in the formu-
lation of the suspected diagnosis. Categorization of patients into
pretest probability groups guides the diagnostic strategy by selecting
patients in whom further tests should be performed.
The most extensively validated predictive model is the original Wells
score, that categorizes patients into low, moderate and high probability
groups, or the simplified version (the Modified Wells Scoring System)
that identifies two categories of probability (EP likely or unlikely).
These models are not fully standardized and are criticized due to the
presence of a subjective criterion (the physicians’ judgement of
whether an alternative diagnosis is less likely than pulmonary em-
bolism) that limits score reproducibility. To overcome this limitation of
the Wells model it was introduced the Geneva Score exclusively based
on objective clinical items [24-26].
During the diagnostic step errors are frequently due to a lack or to
an incongruous acquisition or to a misinterpretation of all clinical
and instrumental available data. Malpractice litigations may also
focus on the inaccurate time management of the investigations, on
the inability to put differential diagnostic hypotheses, resulting in
failure or untimely implementation of treatment protocols for throm-
boembolic disease.
Not only the inability to put differential diagnosis, but also the un-
justified and without a correct purpose use of unnecessary, ineffec-
tive or harmful instrumental tests may represent a wrong medical
conduct. The inaccurate evaluation of the relationship between the
diagnostic efficacy of an investigation and its such clinical risk may
lead to medical liability; from a legal perspective, the standard of care
descended from one side from the acquirement of patient consent
and from the other by the existence of a “necessity state” that justify
medical action because it is aimed at avoiding risk of greater harm
than itself induces.
In the hypothesis of pulmonary embolism, physicians are often
concerned that the introduction of clinical practice guidelines with
the consequent increased use of instrumental tests, although more
invasive (such as the computed tomography angiography) will re-
duce their clinical decision-making authority avoiding malpractice
litigation.
In light of current diagnostic algorithms [23], we must emphasize
the role too often overlooked of the combined assessment of clinical
probability with D-dimer test findings; in patients categorized into
low or moderate clinical probability group the D-dimer test might be
useful as the first step of an instrumental evaluation because pul-
monary embolism can be excluded without any further invasive
testing in a larger proportion of patients (30% of in hospital cases),
resulting in reduced risk associated to use of X-ray contrast media
and ionizing radiation.
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Although it was emphasized the importance of their relevance in a ret-
rospective medico-legal evaluation of the sequence of clinical events
which led to a hypothesis of professional negligence “in order to give
high degree of rational credibility to the hypothesis of causal recon-
struction” [27], an uncritical application of guidelines is not without
risks of imprudent and false interpretation.
Because they are more or less concise statements of what the pro-
fession deems to be appropriate care and not prescriptive and defini-
tive rules of the correct procedures, they constitute a general guide to
be followed. An adequate and justify derogation from guidelines cannot
be mechanically set up as hypothesis of guilt; the medical practitioner’s
judgment in each case must represent a factor not evocative of a
wrongful conduct but indicative of a good clinical practice.
At the same time, the physician who did not recognize in each case
the need to deviate from guidelines could be challenged to a medical
negligence action, as the clinical practice sometimes require to over-
come the information contained in the general guide.
On this point, the decision of the Supreme Criminal Court appears
emblematic: “…regarding guidelines, there is the fear that the same may
provide undue protective hats to sloppy and careless conducts: a proce-
dure is not permissible because it is allowed, but it is allowed why it is
diligent”.
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